Experimental infection of pigs with a classical swine fever virus isolated in Japan for the first time in 26 years

Abstract

Following an outbreak of classical swine fever (CSF) in Japan, 2018, CSFV JPN/1/2018 was isolated from an infected pig sample. In this study, we carried out a comparative experimental infection in pigs using this strain and the highly virulent ALD strain and compared outcomes, including clinical manifestation, virus shedding patterns and antibody responses. Although pigs inoculated orally or intramuscularly with JPN/1/2018 developed hyperthermia and had decreased leucocyte numbers, they survived for the whole experimental period and showed less severe clinical signs than those infected with the ALD strain. We confirmed the presence of characteristic multifocal infarction of the margin of the spleen that arises following infection with JPN/1/2018, albeit that this finding was not observed in all infected pigs. Both viruses efficiently spread to contact pigs in a similar manner, suggesting in transmissibility between the two strains. Viral RNAs were detected in all clinical samples, especially whole blood samples, before the pigs developed hyperthermia until at least approximately 2 weeks after inoculation. Our findings will be valuable for the investigations into epidemic events occurring in Japan and for establishing diagnostic strategies and control measures against CSF.

Full text

Advance Publication
The Journal of Veterinary Medical Science
Accepted Date: 27 June 2019
J-STAGE Advance Published Date: 9 July 2019
©2019 The Japanese Society of Veterinary Science
Author manuscripts have been peer reviewed and accepted for publication but have not yet
been edited.

1
Full paper, Virology
1
2
Experimental infection of pigs with a classical swine fever virus
3
isolated in Japan for the first time in 26 years
4
Ken-ichiro KAMEYAMA1), Tatsuya NISHI1), Manabu Yamada1), Kentaro MASUJIN1), Kazuki MORIOKA1), Takehiro
5
KOKUHO1) and Katsuhiko FUKAI1)*
6
7
1)Exotic Disease Research Unit, Division of Transboundary Animal Diseases, National Institute of Animal Health,
8
National Agriculture and Food Research Organization, 6-20-1, Josui-honcho, Kodaira, Tokyo, 187-0022, Japan
9
10
*Correspondence to: Fukai, K.: fukai@affrc.go.jp
11
12
Running head: INFECTION OF CSFV ISOLATED IN JAPAN
13
14

2
ABSTRACT
15
Following an outbreak of classical swine fever (CSF) in Japan, 2018, CSFV JPN/1/2018 was isolated from
16
an infected pig sample. In this study, we carried out a comparative experimental infection in pigs using this
17
strain and the highly virulent ALD strain and compared outcomes, including clinical manifestation, virus
18
shedding patterns and antibody responses. Although pigs inoculated orally or intramuscularly with JPN/1/2018
19
developed hyperthermia and had decreased leucocyte numbers, they survived for the whole experimental
20
period and showed less severe clinical signs than those infected with the ALD strain. We confirmed the
21
presence of characteristic multifocal infarction of the margin of the spleen that arises following infection with
22
JPN/1/2018, albeit that this finding was not observed in all infected pigs. Both viruses efficiently spread to
23
contact pigs in a similar manner, suggesting in transmissibility between the two strains. Viral RNAs were
24
detected in all clinical samples, especially whole blood samples, before the pigs developed hyperthermia until
25
at least approximately 2 weeks after inoculation. Our findings will be valuable for the investigations into
26
epidemic events occurring in Japan and for establishing diagnostic strategies and control measures against CSF.
27
28
KEY WORDS: classical swine fever virus, experimental infection, Japan
29
30

3
INTRODUCTION
31
Classical swine fever (CSF) is a highly contagious viral disease induced by the classical swine fever virus
32
(CSFV) of the genus Pestivirus in the family Flaviviridae [7]. This disease is widely distributed around the world,
33
including Asian countries. CSFV is classified into three genotypes (1, 2 and 3) and several subgenotypes (1.1–
34
1.4, 2.1–2.3, and 3.1–3.4) [9, 14]. In East and Southeast Asia, several genotypes or subgenotypes of CSFV
35
isolates including 1.1, 2.1–2.3 and 3.4 have been identified [1, 10]. The virulence of the CSFV ranges from highly
36
virulent with almost 100% mortality to avirulent. Although, there is currently no clear evidence of a correlation
37
between genotype and virulence, in general, the most virulent strains such as the ALD strain have genotype 1,
38
while most strains of genotype 2 are moderately virulent. Severity also depends on the characteristics of the
39
host animal including age, breed and health. Some reports have described difficulties obtaining clinical CSF
40
diagnoses on infected farms because of low severities [17, 19]. In addition, a CSFV isolate newly classified into
41
subgenotype 2.1d in China has been characterized as moderately virulent [11].
42
In Japan, the first outbreak of CSF was reported in 1888 and subsequent outbreaks occurred repeatedly
43
for over one hundred years [2]. However, after the first use of GP live vaccine, which was developed from the
44
attenuated CSFV strain GPE- [18], the number of CSF infections drastically decreased, with the last outbreak
45
occurring in 1992. In 2007, Japan was given CSF-free status from World Organization for Animal Health.
46
However, in September, 2018, a CSF outbreak occurred in Gifu Prefecture, Japan for the first time in 26 years.
47
CSFV JPN/1/2018, which was isolated from an infected pig, was classified into the subgenotype 2.1 [13, 15].
48
This is the first isolate of CSFV in this lineage reported in Japan.
49
To evaluate the virulence of the isolate and the clinical manifestations of the associated infection, we
50
conducted a comparative animal experiment using high virulent ALD strain.
51
52
MATERIALS AND METHODS
53
54
Ethics
55

4
The Animal Care and Use Committee of the National Institute of Animal Health (NIAH) approved all
56
animal procedures prior to the initiation of this study (authorization number: 18-047). All experimental
57
infections using live viruses were performed in a high-containment facility at the NIAH. The high-containment
58
facility is compliant with a containment level for group 4 pathogens described in the OIE Manual of Diagnostic
59
Tests and Vaccines for Terrestrial Animals 2018 [21].
60
61
Cells and viruses
62
CPK cells were used in this study. The cells were maintained using Dulbecco’s Modified Eagle Medium:
63
Nutrient Mixture F12 (Thermo Fisher Scientific, Waltham, MA, U.S.A.) supplemented with 10% of pestivirus-
64
free fetal calf serum. The CSFV JPN/1/2018 was isolated from a whole blood sample collected from the first
65
reported case in the 2018 outbreak in Japan. It was initially isolated using CPK cells and propagated once by
66
the same cells. The highly virulent ALD strain was also used as an inoculum for pigs. The ALD strain preserved
67
in our institute was propagated once by CPK cells before use.
68
69
Experimental infections
70
Twelve 8-week-old crossbreed Landrace × Large White × Duroc pigs were used for this study. The pigs
71
were confirmed not to have antibodies against pestivirus before the experimental infections. Half of them were
72
directly inoculated with CSFVs and the remaining animals were cohabited with inoculated pigs (contact
73
animals). Two pigs each were orally (Group 1, Nos. 1 and 2) or intramuscularly (Group 2, Nos. 5 and 6)
74
administered 1ml of 106.5 50% tissue culture infectious dose (TCID50) of JPN/1/2018 strain, and two pigs were
75
injected intramuscularly with 1ml of 106.5 TCID50 of the high virulent ALD strain (Group 3, Nos. 9 and 10). For
76
oral administration, the strain was directly dropped onto tonsil. The day after inoculation, 2 more pigs were
77
introduced to each group (Nos. 3 and 4 for Group 1, Nos. 7 and 8 for Group 2, and Nos. 11 and 12 for Group 3)
78
and a total of 4 pigs were housed together in each room. During the experiment period, clinical samples
79
(heparinized whole blood, sera, saliva, nasal swabs, and feces) were collected daily. Saliva, nasal swabs and
80
feces were mixed with a 10 times volume of phosphate buffered saline and filtered by 0.45 μm centrifugal
81

5
filter unit (Ultrafree-MC/CL, Merck Millipore, Darmstadt, Germany). For all animals, clinical signs were
82
observed and total leucocyte numbers in the whole blood were counted daily using Turk’s solution and a
83
disposable hemocytometer (C-Chip, NanoEn Tek Inc., Seoul, South Korea) for approximately 2 weeks.
84
85
RNA extraction and RT-PCR
86
Viral RNAs were extracted from the clinical samples using the High Pure Viral RNA kit (Roche Diagnostics,
87
Basel, Switzerland) according to manufacturer’s instructions. Viral genes were amplified with SuperScript III
88
One-Step RT-PCR System with Platinum Taq DNA Polymerase (Thermo Fisher Scientific) using primers 324 and
89
326 [20]. PCR products were separated by electrophoresis on a 1% agarose gels and visualized by staining with
90
ethidium bromide and visualized using UV-light transillumination. The RT-PCR assay can detect the minimum
91
100.5 TCID50/ml of JPN/1/2018 strain according to our evaluation (data not shown).
92
93
Fluorescent antibody (FA) test
94
The tonsils of infected pigs were frozen in N-hexane cooled by liquid nitrogen. The frozen samples were
95
cut into thin sections using a cryostat, reacted with FITC-labeled specific antibody for CSFV (Classical Swine
96
Fever-FA, Kyoto Biken Lab. Inc., Kyoto, Japan) and observed under a fluorescence microscope (LSM 700, Carl
97
zeiss, Tokyo, Japan).
98
99
Enzyme-linked immunosorbent assay (ELISA)
100
Anti-CSFV antibodies in the serum samples collected from pigs were examined by a CSFV-specific ELISA
101
kit (Classical Swine Fever ELISA kit II, JNC Corp., Tokyo, Japan) according to manufacturer’s instructions [16].
102
103
Scoring of CSF symptoms and pathological findings at autopsy
104
To evaluate the virulence of CSFV strains JPN/1/2018 and ALD, a clinical score (CS) was determined using
105
the criteria of Mittelholzer et al. [12]. Virus strains were classified as highly virulent (peak CS>15), moderately
106
virulent (CS 5 to 15), low virulent (CS<5) or avirulent (CS 0). While the original method is scoring all parameters
107

6
daily, we estimated the score for the most severe symptoms in each pig throughout the experiment period.
108
After clinical assessment, the pigs were euthanized then subjected to postmortem examination. A pathological
109
score (PS) of each pig was determined using the method reported by Floegel-Niesmann et al. [3].
110
111
RESULTS
112
113
Clinical manifestations
114
The inoculated pigs of Group 3 (inoculated with ALD) showed diarrhea, dysstasia, abolition of appetite
115
and neurological symptoms (abnormal swimming behavior) at 5 days post infection (dpi) (Fig. 1). Those pigs
116
were euthanized at 5 dpi because they were apparently moribund. Contact pigs housed with inoculated pigs
117
in Group 3 also showed similar clinical symptoms, although these pigs survived for the whole experimental
118
period (until 12 days post contact (dpc)). Therefore, estimated CSs for pigs in Group 3 were in the range 18–
119
19, indicating high virulence (Table 1). In contrast, pigs in Group2 (inoculated intramuscularly with JPN/1/2018)
120
and Group 1 (inoculated orally with JPN/1/2018) showed less severe symptoms. Although they showed areas
121
of reddened skin (Fig. 1c), and three of four pigs developed conjunctivitis (Fig. 1d) (Table 1), all pigs of Group
122
2 survived for the whole experiment period (14 dpi and 13 dpc). Pigs in Group 1 showed anorexia and
123
stiffness/body tension, as well as areas of reddened skin and conjunctivitis, and survived for the whole
124
experimental terms (15 dpi and 14 dpc). Estimated CSs for pigs in Groups 1 and 2 were in the range 1–5,
125
suggesting low to moderate virulence.
126
Body temperature and leucocyte number are shown in Fig. 2. The body temperature of inoculated pigs
127
in Group 3 were over 40oC at 1–2 dpi. A decrease in leukocyte number (under 10,000 cells/μl) was
128
simultaneously observed. Contact pigs that housed with the inoculated pigs showed high fever and decreased
129
leukocyte number from 7–8 dpc and 6–7 dpc, respectively. In contrast, infected pigs in Groups 1 and 2 showed
130
fever at 4–7 dpi and 8–12 dpi, respectively, while the decrease in leukocyte number was observed before the
131
fever (2–3 dpi). One of two contact pigs housed with inoculated pigs in Groups 1 and 2 showed high fever at 8
132

7
and 12 dpc, respectively, and all contact pigs showed decreased leukocyte numbers until 13 or 14 dpc. In
133
contrast, 2 contact pigs (Nos. 4 and 7) did not show fever over 40oC during the experimental period.
134
135
Detection of CSFV viral RNA (vRNA), antigen and antibody from clinical samples
136
vRNAs were detected from whole blood, sera, saliva, nasal swabs, and feces of the all pigs, including
137
contact animals (Table 2). vRNAs were detected at 1–2 dpi in samples from inoculated animals in Group 3, and
138
at 3 dpi in samples from inoculated animals in Groups 1 and 2. In contrast, vRNAs were detected in the blood
139
of contact pigs from 5, 4–8 and 4–7 days after virus shedding from inoculated pigs in Groups 3, 2 and 1,
140
respectively (Table 2). Crypt epithelial cells in tonsils of all infected animals showed positive for CSFV antigen
141
using the FA test (Fig. 3). Anti-CSF antibodies were only detected from 4 pigs (No. 2 on 14 dpi, No. 8 on 14 dpc,
142
and Nos. 5 and 6 on 15 dpi) during the experimental period.
143
144
Pathological findings
145
The PSs of the infected and contact pigs in Groups 1 and 2 (0–10) were lower than those in Group 3 (8–
146
13) (Table 3). Among the pigs of Group 3, three of four pigs showed hyperemia in the brain, congestion and
147
whitish clouding of the meninges or swollen of the meningeal blood vessels (Fig. 4a). In contrast, only one out
148
of eight pigs in Groups 1 and 2 showed swelling of the meningeal blood vessels in the brain. Further, all four
149
pigs in Group 3 showed multifocal necrosis and formation of small abscesses in the tonsil (Fig. 4b), while no
150
significant lesions were observed in the tonsil of any pigs in Groups 1 and 2. Petechial hemorrhages in the
151
kidney of the pigs in Group 3 appeared more severer than those of pigs in Groups 1 and 2. There was no
152
significant differences in the pathological findings in the spleen, lymph nodes, intestine or skin between the
153
pigs in Group 3 and those in Groups 1 and 2 (Table 3). Multifocal infarction of the margin of spleen and
154
hemorrhagic lymph nodes were observed in four in eight pigs of Groups 1 and 2 (Fig. 4c) and three out of four
155
pigs in Group 3. Button ulcers in the colon were found in two infected pigs in Groups 1 and 2 (Nos. 1 and 6)
156
(Fig. 4d) and in one pig in Group 3 (No. 12). There was no pathological finding in the respiratory organs of any
157
pig.
158

8
159
DISCUSSION
160
161
In this study, vRNAs of JPN/1/2018 and ALD strains were detected from clinical samples of all infected
162
pigs (Table 2), and anti-CSFV antibodies were detected in some pigs on day 14–15 (data not shown). We
163
confirmed that JPN/1/2018 infection of pigs via both oral and intramuscular routes and transmitted
164
horizontally to contact pigs in a similar manner to the virulent ALD strain. The clinical symptoms of JPN/1/2018
165
infected pigs were only pyrexia, hypodynamia, anorexia and conjunctivitis only. These were milder than the
166
symptoms observed in ALD infected pigs, and no pigs infected with JPN/1/2018 died or were euthanized within
167
the 2-week experimental period. Two of five pigs infected experimentally with a subgenotype 2.1 CSFV isolated
168
in Mongolia did not show any clinical signs during an experimental period of 2 weeks [4]. In addition, all pigs
169
were alive during the experimental period. Authors of the experiment judged that pathogenicity of the
170
subgenotype 2.1 CSFV is moderately virulent by comparing the pathogenicity with those of highly virulent and
171
vaccine strains. Clinical signs in this study were similar with those in their study; therefore, pathogenicity of
172
JPN/1/2018 strain is also moderately virulent.
173
To assess the pathogenicity, we scored the clinical and pathological symptoms [3, 12]. ALD infected pigs
174
showed high PCs due to necrosis in the tonsil tissue and vascular swelling in the brain. Estimation of CSs in this
175
study was simpler than the original method. Scores of the JPN/1/2018 infected pigs were markedly lower than
176
those of the ALD infected animals. These results suggest that the JPN/1/2018 strain is less virulent than ALD.
177
Meanwhile, there was no significant difference in the period of transmission from infected to contact pigs
178
between the ALD and JPN/1/2018 strains (Table 2), suggesting similar transmissibility of both virus strains.
179
Analysis of the pathogenicity of a subgenotype 2.1 CSFV isolated in China showed that transmissibility of the
180
subgenotype 2.1 CSFV was expected to be significantly lower than that of a high virulent strain because virus
181
excretion in pigs inoculated with the subgenotype 2.1 CSFV was significantly delayed than that in pigs
182
inoculated with the high virulent strain [11]. Results in the previous and our studies cannot compare directly
183
because virus strains, infectious doses and ages of pigs were different in both the studies; however, it is
184

9
interesting that transmissibility of JPN/1/2018 and ALD strain is similar in this study although pathogenicity of
185
JPN/1/2018 strain was apparently milder than that of ALD strain. In contrast, although we confirmed the
186
presence of characteristic multifocal infarction of the margin of the spleen after oral and intramuscular
187
inoculation with JPN/1/2018, these lesions were not observed in all infected pigs and it was difficult to
188
diagnose CSF only by antemortem inspection because multifocal infarction of spleen are not always confirmed
189
in all CSF-affected pigs [7]. Therefore, in addition to the antemortem inspection, the FA test needs to be
190
performed using tonsil samples collected from suspected pigs that are affected CSF. In contrast, there were
191
several cases that apparent clinical signs were not confirmed in recent CSF cases in Japan [personal
192
communication). Taken together, these findings suggest that in addition to clinical and antemortem inspections
193
including the FA test, molecular and serological laboratory tests should be performed to accurately determine
194
the presence of infection with JPN/1/2018.
195
Loforban et al. previously described a difference in infectivity between intramuscular and intranasal
196
infections of CSFV [8]. Pigs intramuscularly inoculated with CSFV showed typical lesions while those that were
197
intranasally inoculated did not. In contrast, the pathological findings in JPN/1/2018 orally- and intramuscularly-
198
inoculated pigs in the present study were comparable. The reason of this discrepancy between the previous
199
and our present study is unclear. However, the fact that we conducted oral administration by directly dropping
200
CSFV onto the tonsil may be a contributing factor. Previous studies have reported that epithelial cells in the
201
tonsillar crypt and mononuclear cells that accumulate to tonsils are sensitive to CSFVs [5, 6]. Therefore, direct
202
administration of the CSFV onto the tonsils presumably enhances primary virus propagation at the site of
203
infection and affects aggravations in orally infected pigs.
204
In conclusion, the results of this study show that the pigs infected with the JPN/1/2018 strain shed viruses
205
into clinical samples, especially whole blood samples, before the appearance of high fever, until at least
206
approximately 2 weeks after infection. The results are expected to be of significant value in establishing
207
appropriate countermeasures and diagnostic strategies for the JPN/1/2018 strain.
208
209
ACKNOWLEDGMENTS
210

10
The author would like to thank Mr. Takayoshi Shiratori (Yamagata Prefectural Shonai Animal Hygiene
211
Service Center, Yamagata), Mr. Shunjiro Koizumi (Saitama Prefectural Central District Animal Hygiene Service
212
Center, Saitama) and Mr. Kosuke Ohashi (Osaka Prefectural Animal Hygiene Service Center) for technical
213
assistance. We also thank Mr. Yuuki Takahashi, Mr. Masayuki Kanda, Mr. Kenichi Ishii, Mr. Tatsuo Nakamura,
214
Mr. Masami Wada and Mr. Shigeo Mizumura for their care of the animals.
215
216
REFERENCES
217
1. Beer, M., Goller, K. V., Staubach, C. and Blome, S. 2015. Genetic variability and distribution of Classical
218
swine fever virus. Anim. Health Res. Rev., 16: 33–39.
219
2. Edwards, S., Fukusho, A., Lefèvre, P. C., Lipowski, A., Pejsak, Z., Roehe, P. and Westergaard, J. 2000.
220
Classical swine fever: the global situation. Vet. Microbiol. 73: 103–119.
221
3. Floegel-Niesmann, G., Bunzenthal, C., Fischer, S. and Moennig, V. 2003. Virulence of recent and former
222
classical swine fever virus isolates evaluated by their clinical and pathological signs. J. Vet. Med. B Infect.
223
Dis. Vet. Public Health 50: 214–220.
224
4. Enkhbold, B., Shatar, M., Wakamori, S., Tamura, T., Hiono, T., Matsuno, K., Okamatsu, M., Umemura, T.,
225
Damdinjav, B., Sakoda, Y. 2017. Genetic and virulence characterization of classical swine fever viruses
226
isolated in Mongolia from 2007 to 2015. Virus Genes 53: 418–425.
227
5. Gisler, A. C., Nardi, N. B., Nonnig, R. B., Oliveira. L. G. and Roehe, P. M. 1999. Classical swine fever virus in
228
plasma and peripheral blood mononuclear cells of acutely infected swine. Zentralbl. Veterinarmed. B. 46:
229
585–593.
230
6. Horter, D. C., Yoon, K. J. and Zimmerman, J. J., 2003. A review of porcine tonsils in immunity and disease.
231
Anim. Health. Res. Rev. 4: 143–155.
232
7. Kirkland, P. D., Le Potier, M. F., Vannier, P. and Finlaison, D. 2012. Pestiviruses. pp. 538–553. In: Diseases
233
of swine, 10th ed. (Zimmerman, J. J., Karriker, L. A., Ramirez, A., Schwartz, K. J. and Stevenson, G. W. eds.),
234
John Wiley & Sons, West Sussex.
235

11
8. Leforban, Y. and Cariolet, R., 1992. Characterization and pathogenicity for pigs of a hog cholera virus strain
236
isolated from wild boars. Ann Rech. Vet. 23: 93–100.
237
9. Lowings, P., Ibata, G., Needham, J. and Paton, D., 1996. Classical swine fever virus diversity and evolution.
238
J. Gen. Virol. 77: 1311–1321.
239
10. Luo, Y, Li, S., Sun, Y. and Qiu, H. J. 2014. Classical swine fever in China: a minireview. Vet. Microbiol. 172:
240
1–6.
241
11. Luo, Y., Ji, S., Liu, Y., Lei, J. L., Xia, S. L., Wang, Y., Du, M. L., Shao, L., Meng, X. Y., Zhou, M., Sun, Y. and Qiu,
242
H. J. 2017. Isolation and Characterization of a Moderately Virulent Classical Swine Fever Virus Emerging
243
in China. Transbound. Emerg. Dis. 64: 1848–1857.
244
12. Mittelholzer, C., Moser, C., Tratschin, J. D. and Hofmann, M. A. 2000. Analysis of classical swine fever virus
245
replication kinetics allows differentiation of highly virulent from avirulent strains. Vet. Microbiol., 74: 293–
246
308.
247
13. Nishi, T., Kameyama, K., Kato, T. and Fukai, K., 2019. Genome sequence of a classical swine fever virus of
248
subgenotype 2.1 isolated from a pig in Japan in 2018. Microbiol. Resour. Announc., 8: e01362-18.
249
14. Paton, D. J., McGoldrick, A., Greiser-Wilke, I., Parchariyanon, S., Song, J. Y., Liou, P. P., Stadejek, T., Lowings,
250
J. P., Björklund, H. and Belák, S., 2000. Genetic typing of classical swine fever virus. Vet. Microbiol. 73:137–
251
157.
252
15. Postel, A., Nishi, T., Kameyama, K., Meyer, D., Suckstorff, O., Fukai, K., Becher, P., 2019. Reemergence of
253
classical swine fever, Japan, 2018. Emerg. Infect. Dis., 25:1228–1231.
254
16. Sakoda, Y., Wakamoto, H., Tamura, T., Nomura, T., Naito, M., Aoki, H., Morita, H., Kida, H., Fukusho, A.
255
2012. Development and evaluation of indirect enzyme-linked immunosorbent assay for a screening test
256
to detect antibodies against classical swine fever virus. Jpn. J. Vet. Res., 60: 85–94.
257
17. Sandvik, T., Drew, T. and Paton, D. 2000. CSF virus in East Anglia: where from? Vet. Rec. 147: 251.
258
18. Shimizu, Y., Furuuchi, S., Kumagai, T. and Sasahara, J. 1970. A mutant of hog cholera virus inducing
259
interference in swine testicle cell cultures. Am J Vet Res., 31: 1787–1794.
260

12
19. Terpstra, C. and de Smit, A. J. 2000. The 1997/1998 epizootic of swine fever in the Netherlands: control
261
strategies under a non-vaccination regimen. Vet. Microbiol. 77: 3–15.
262
20. Vilcek, S., Herring, A. J., Herring, J. A., Nettleton, P. F., Lowings, J. P. and Paton, D.J. 1994. Pestiviruses
263
isolated from pigs, cattle and sheep can be allocated into at least three genogroups using polymerase
264
chain reaction and restriction endonuclease analysis. Arch. Virol., 136: 309–323.
265
21. World Organization for Animal Health. 2018. Chapter 1.1.4. Biosafety and biosecurity: Standard for
266
managing biological risk in the veterinary laboratory and animal facilities,
267
http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/1.01.04_BIOSAFETY_BIOSECURITY.pd
268
f [accessed on February 27, 2019]
269
270

13
FIGURE LEGENDS
271
Fig. 1. Clinical findings of pigs of Groups 1–3. (a) Diarrhea in pig No. 10 at 3 dpi. (b) Severe neurological
272
symptoms of abnormal swimming behavior in pigs Nos. 9 and 10 at 5 dpi. (c) Reddened skin in the
273
hypogastrium in pig No. 6 at 15 dpi. (d) Congestion in the palpebral conjunctiva in pig No. 5 at 8 dpi.
274
275
Fig.2. Body temperature and leucocyte number in pigs of Groups 1–3. Body temperature (solid line) and
276
leucocyte counts (dotted line) from Groups 1–3 were shown. Pig Nos. 9 and 10 were euthanized at 5 dpi. (#)
277
Pig number.
278
279
Fig. 3. Fluorescent antibody assay. Pig No.3. Specific antigen was is clearly detected in the crypt epithelial cells
280
in the tonsil at 14 dpi.
281
282
Fig. 4. Pathological findings in pigs of Groups 1–3. (a) Congestion and whitish clouding of the meninges in pig
283
No. 10 at 5 dpi. (b) Formation of multiple abscesses (white arrows) in the tonsil in pigs No. 9 at 5 dpi. (c)
284
Multifocal hemorrhagic infarction of the margin of the spleen in pig No. 2 at 14 dpi. (d) Button ulcers (black
285
arrows) in the colon in pig No. 1 at 14 dpi.
286
287

Group
Pig
Liveliness 1
(4 dpia))1 (4 dpi) 0 0 0 0 0 0 3 (5 dpi) 3 (5 dpi) 3
(8 dpcb))
3 (8 dpc)
Body tension 1 (5 dpi) 1 (5 dpi) 0 0 0 0 0 0 3 (5 dpi) 3 (5 dpi) 3 (10 dpc) 3 (10 dpc)
Body shape 0 0 0 0 0 0 0 0 1 (5 dpi) 1 (5 dpi) 0 1 (12 dpc)
Breathing 0 0 0 0 0 0 0 0 0 0 0 0
Walking (neurological signs) 0 0 0 0 0 0 0 0 3 (5 dpi) 3 (5 dpi) 3 (8 dpc) 3 (8 dpc)
Skin 1 (14 dpi) 1 (14 dpi) 1 (13 dpc) 1 (13 dpc) 1 (15 dpi) 2 (15 dpi) 0 1 (14 dpc) 0 1 (5 dpi) 2 (12 dpc) 1 (12 dpc)
Eyes (conjunctivitis) 1 (14 dpi) 1 (9 dpi) 2 (13 dpc) 0 2 (8 dpi) 1 (9 dpi) 2 (14 dpc) 0 2 (4 dpi) 2 (5 dpi) 2 (9 dpc) 2 (9 dpc)
Appetite 1 (7 dpi) 1 (7 dpi) 0 0 0 0 0 0 3 (5 dpi) 3 (5 dpi) 3 (8 dpc) 3 (8 dpc)
Defecation 0 0 0 0 0 0 0 0 3 (5 dpi) 3 (3 dpi) 3 (9 dpc) 3 (12 dpc)
Total points 5 5 3 1 3 3 2 1 18 19 19 19
a) days post inoculation
b) days post contact
No.5
Contact
Inoculated
Contact
Inoculated
No.12
Table 1 Clinical scores of experimental pigs
No.6
No.7
No.8
No.9
No.10
No.11
Group 2 (JPN/1/2018 intramuscularly)
Group 3 (ALD intramuscularly)
No.1
No.2
No.3
No.4
Contact
Administrated
Group 1 (JPN/1/2018 intraoral)

Group
dpi
(dpc)a)
0 1 (0) 2 (1) 3 (2) 4 (3) 5 (4) 6 (5) 7 (6) 8 (7) 9 (8) 10 (9) 11 (10) 12 (11) 13 (12) 14 (13) 15 (14)
No.1 −/−/−/−/−
b) −/−/−/−/− −/−/−/−/− −/+/−/−/−+/+/−/−/−+/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT +/+/+/+/+ NT
No.2 −/−/−/−/− −/−/−/−/− −/−/−/−/−
−/+/−/−/−+/+/+/+/−+/+/+/+/−+/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT +/+/+/+/+ NT
No.3 NT −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/−
−/+/−/−/− −/−/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT +/+/+/+/+ NT
No.4 NT −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/−
−/−/−/−/− −/−/+/−/− −/−/+/−/− −/−/+/−/− −/−/+/+/− −/−/+/+/− −/+/+/+/+ NT +/+/+/+/−NT
No.5 −/−/−/−/− −/−/−/−/− −/−/−/−/−
+/+/+/−/−+/+/+/+/−+/+/+/+/−+/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT NT +/+/+/+/+
No.6 −/−/−/−/− −/−/−/−/− −/−/−/−/−
+/+/−/−/−+/+/+/−/−+/+/+/+/−+/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT NT +/+/+/+/+
No.7 NT −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/−
−/−/+/+/− −/−/+/+/− −/−/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT NT +/+/+/+/+
No.8 NT −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/−
+/+/+/−/−+/+/+/−/−+/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT NT +/+/+/+/+
No.9 −/−/−/−/− −/−/−/−/− +/+/+/−/− +/+/+/+/− +/+/+/+/− +/+/+/+/+ NT NT NT NT NT NT NT NT NT NT
No.10 −/−/−/−/− −/+/−/−/− +/+/+/+/− +/+/+/+/− +/+/+/+/+ +/+/+/+/+ NT NT NT NT NT NT NT NT NT NT
No.11 NT −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/−
−/−/+/−/−−/−/−/−/− +/+/−/−/−+/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT NT
No.12 NT −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/− −/−/−/−/−
+/+/−/−/−+/+/−/−/−+/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ +/+/+/+/+ NT NT
Table 2 Detection of classical swine fever (CSF) vRNA from clinical samples by RT-PCR
a) dpi: days post inoculation, dpc: days post contact
b) serum/whole blood/saliva/nasal swab/ feces. NT: not tested. Days when CSF vRNAs were detected from only the whole blood samples are colored light orange. Days when CSF vRNAs were detected
from all samples are colored orange.
Group 1
(JPN/1/2018
oral)
Group 2
(JPN/1/2018 im)
Group 3
(ALD im)

Group
Pig No.1 No.2 No.3 No.4 No.5 No.6 No.7 No.8 No.9 No.10 No.11 No.12
Skin 1 1 1 1 1 2 0 1 0 1 2 1
Subcutis and serosae 0 0 0 0 0 0 0 0 0 0 0 0
Tonsil 0 0 0 0 0 0 0 0 3 3 3 3
Spleen 2 3 2 0 0 0 0 1 2 2 0 1
Kidney 0 0 1 0 0 0 0 0 1 1 1 0
Lymph nodes 2 2 2 0 0 0 0 2 2 2 2 0
Intestine from ileum to rectum 3 0 0 0 0 3 0 0 0 1 0 3
Brain 2 0 0 0 0 0 0 0 0 3 3 3
Respiratory system 0 0 0 0 0 0 0 0 0 0 0 0
Total points 10 6 6 1 1 5 0 4 8 13 11 11
Contact
Table 3 Pathological scores of experimental pigs
Group 1 (JPN/1/2018 intraoral)
Group 2 (JPN/1/2018 intramuscularly)
Group 3 (ALD intramuscularly)
Administrated
Contact
Inoculated
Contact
Inoculated